New Study Finds Improved Long-Term Neurodevelopmental Outcomes for Extremely Premature Infants Fed Prolacta’s Exclusive Human Milk Diet (EHMD)

Preterm Infants Who Received Prolacta's 100% Human Milk-Based Fortifiers as Part of an EHMD in the NICU Had Improved Developmental Outcomes at Age 2, Findings Show DUARTE, Calif., Nov. 9, 2022 /PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human...

Click to view original post